BRUSSELS, Oct. 8 (Xinhua) -- The European Commission on Thursday signed a joint procurement framework contract with American pharmaceutical company Gilead for the supply of up to 500,000 treatment courses of Remdesivir.
The signature followed a previous contract with Gilead to secure 33,380 treatment courses of Veklury, the brand name for Remdesivir, which have been distributed across the European Union (EU) and the United Kingdom since August.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!